MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-TS-09-0046886
Vamsi Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹17.11 Cr
▲ 16% YoY
Net profit · FY 2025
₹2.34 Cr
Net margin 13.7%
EBITDA · FY 2025
₹4.96 Cr
EBITDA margin 29%
Authorised capital
₹17.5 Cr
Registered with MCA
Paid-up capital
₹15.63 Cr
Issued & subscribed
Open charges
₹25.86 Cr
Satisfied ₹2 Cr
Company age
11 yrs
Est. 2015
Employees · EPFO
32
Provident fund records
About Vamsi Pharma Private Limited
Data last updated:
Vamsi Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 July 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2015PTC099814. Its GSTIN is 36AAFCV2039L1Z3 (Telangana).
The company has an authorised share capital of ₹17.5 Cr and a paid-up capital of ₹15.63 Cr. It is led by directors including Ravindra Nandlal Purohit (Managing Director) and Pratap Reddy Linga Reddy Gaddam.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Sy. No. 707 & 708 Nandi Gama Village Mekagudem Gp Kothur Mandal, Hyderabad, Telangana, India – 509228.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.11 Cr, a growth of 16% compared to the previous year. For the same year it recorded a net profit of ₹2.34 Cr (net margin 13.7%) and EBITDA of ₹4.96 Cr (EBITDA margin 29%). Revenue has grown at a compounded annual rate (CAGR) of 116% over three years and 57% over five years.
The company has about 32 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Vamsi Pharma. As per MCA filings, the company has open charges of ₹25.86 Cr and satisfied charges of ₹2 Cr on record. The company has 4 deals on record (3 rights issues, 1 secondary share transfer); the latest was in January 2022. Its 3 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 1 larger and 2 smaller; the largest is Wayonext Pharmaceuticals Private Limited with revenue of ₹17.13 Cr. The company has 2 MSME Form 1 returns on record between 2022 and 2023, listing 22 overdue payments to 17 micro and small suppliers.
Vamsi Pharma Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-TS-09-0046886). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website vamsipharma.com.
Company details
CIN U24100TG2015PTC099814
Registration Number 099814
Incorporation Date 16 July 2015
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-TS-09-0046886
Key People
Ravindra Nandlal Purohit Managing Director Pratap Reddy Linga Reddy Gaddam Director Madhusudan Reddy Padira Director Recognitions & Rankings of Vamsi Pharma
Contact details
Vamsi Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is vamsipharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSy. No. 707 & 708 Nandi Gama Village Mekagudem Gp Kothur Mandal, Hyderabad, Telangana, India – 509228
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Vamsi Pharma Private Limited, buy the company report.
Comprehensive company report
Vamsi Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Vamsi Pharma operates one associated brand: Vamsi Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops and manufactures active pharmaceutical ingredients and intermediates. | vamsipharma.com |
Business activity
The main business activity of Vamsi Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Vamsi Pharma Private Limited, buy the company report.
Financials of Vamsi Pharma Private Limited
FY 2024 filings availableVamsi Pharma Private Limited reported revenue of ₹17.11 Cr (up 16% YoY) for FY 2025.
Revenue · FY 2025
₹17.11 Cr ▲ 16%
Net profit · FY 2025
₹2.34 Cr margin 13.7%
EBITDA · FY 2025
₹4.96 Cr margin 29%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 16%
3 years · compounded
▲ 116%
5 years · compounded
▲ 57%
EBITDA CAGR growth
1 year
▲ 41%
3 years · compounded
▲ 154%
5 years · compounded
▲ 42%
Revenue has grown at a compounded annual rate (CAGR) of 57% over five years, including 16% growth in the latest year. EBITDA rose 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.96 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2.34 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 29% | ||||
| Net Profit Margin | 13.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Vamsi Pharma Private Limited, buy the company report.
Board of directors of Vamsi Pharma Private Limited
Vamsi Pharma has 5 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pratap Reddy Linga Reddy Gaddam Also directs: Sarojini Steel Limited | Director | 16 Jul 2015 | 11 Years 3 Months | Current |
| Madhusudan Reddy Padira | Director | 16 Jul 2015 | 11 Years 3 Months | Current |
| Prashant Nalinaksh Garg | Director | 02 Sep 2022 | 4 Years 1 Months | Current |
| Ravindra Nandlal Purohit Also directs: Vamsi Labs Limited | Managing Director | 16 Jul 2015 | 11 Years 3 Months | Current |
| Keshava Reddy Madana Also directs: Greenfield Cet Plant Private Limited, Vamsi Lifesciences Private Limited, Vamsi Labs Limited and 1 more | Director | 16 Jul 2015 | 11 Years 3 Months | Current |
Peer comparison
Vamsi Pharma Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wayonext Pharmaceuticals Private Limited | ₹17.13 Cr (FY 2025) | 74.0% | Kalyan, Maharashtra, India | |||
| Vamsi Pharma Private Limitedthis company | ₹17.11 Cr (FY 2025) | ₹2.34 Cr | 13.7% | 16.0% | 32 | Hyderabad, Telangana, India |
| JMM Formulation Private Limited | ₹17.04 Cr (FY 2025) | 30.0% | Kala Amb, Himachal Pradesh, India | |||
| Anchor Pharma Private Limited | ₹17.02 Cr (FY 2025) | 11.0% | Daman, Daman and Diu, India |
To see the full peer comparison of Vamsi Pharma Private Limited, buy the company report.
Auditor
Vamsi Pharma Private Limited is audited by NAGA MAHESWARA REDDY & CO. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| NAGA MAHESWARA REDDY & CO. | FY 2023 | 014505S |
Shareholding
The shareholding of Vamsi Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Vamsi Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹25.86 Cr
Satisfied charges
₹2 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 19 May 2025 | 101108346 | State Bank of India | ₹8.49 Cr | Open | |
| 01 Oct 2016 | 100055778 | State Bank of India | ₹17.37 Cr | Open | |
| 30 Nov 2015 | 10616884 | Reliance Capital Ltd | ₹2 Cr | Satisfied |
To see the full charge records of Vamsi Pharma Private Limited, buy the company report.
Total charge records: 3 View all charges
Deals & funding
Vamsi Pharma Private Limited has 4 deals on record (3 rights issues, 1 secondary share transfer); the latest was in January 2022.
Total deals
4
Rights issues
3
Secondary share transfer
1
Deals on record (3 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2022 | Rights issue | ₹2.82 Cr | Investors: 4 individuals |
| Mar 2018 | Rights issue | ₹1.65 Cr | Investors: 4 individuals |
| Mar 2016 | Rights issue | ₹3.34 Cr | Investors: 4 individuals |
To see the full deal history of Vamsi Pharma Private Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
No court or tribunal cases involving Vamsi Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
Credit ratings & regulatory alerts
Vamsi Pharma Private Limited was last rated by Icra on 26 May 2022.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 26 May 2022 |
To see the full credit ratings and regulatory alerts of Vamsi Pharma Private Limited, buy the company report.
MSME payment delays
Vamsi Pharma Private Limited has 2 MSME Form 1 returns on record between 2022 and 2023, listing 22 overdue payments to 17 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 17)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Indian Engineering Refrigration Co | |||
| Sun Life Sciences | |||
| an individual supplier | |||
| an individual supplier | |||
| Exechon |
To see the full MSME payment records of Vamsi Pharma Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Vamsi Pharma Private Limited has a workforce of 32 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
32
Active EPFO establishments
1
GST
Vamsi Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAFCV2039L1Z3 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Vamsi Pharma Private Limited, buy the company report.
Recent activity
Vamsi Pharma Private Limited has 7 board changes on record since 2015: 5 appointments and 2 cessations. The latest: Ravindra Nandlal Purohit ceased to be Director on 31 Mar 2024.
Charges
A charge with State Bank Of India amounted to Rs. 8.49 Cr with Charge ID 101108346 was registered on 19 May 2025.
AGM
Vamsi Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Vamsi Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad.
Ceased
Ravindra Nandlal Purohit ceased to be Director.
Ceased
Prashant Nalinaksh Garg ceased to be Additional Director.
Appointed
Prashant Nalinaksh Garg was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 17.37 Cr registered on 01 Oct 2016 with Charge ID 100055778 was modified on 29 Nov 2021.
Charges
A charge registered on 30 Nov 2015 via Charge ID 10616884 with Reliance Capital Ltd was fully satisfied on 19 Nov 2016.
Charges
A charge with State Bank Of India amounted to Rs. 17.37 Cr with Charge ID 100055778 was registered on 01 Oct 2016.
Charges
A charge with Reliance Capital Ltd amounted to Rs. 2.00 Cr with Charge ID 10616884 was registered on 30 Nov 2015.
Appointed
Keshava Reddy Madana was appointed as Director.
Appointed
Madhusudan Reddy Padira was appointed as Director.
3 earlier events are in the company report.
Frequently asked questions
Vamsi Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 July 2015 (11+ years old) and is registered under CIN U24100TG2015PTC099814.
Vamsi Pharma has 5 current directors:
- Ravindra Nandlal Purohit - Managing Director
- Pratap Reddy Linga Reddy Gaddam - Director
- Madhusudan Reddy Padira - Director
- Prashant Nalinaksh Garg - Director
- Keshava Reddy Madana - Director
The latest financial statements of Vamsi Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Vamsi Pharma is 36AAFCV2039L1Z3, registered in Telangana.
The CIN (Corporate Identification Number) of Vamsi Pharma is U24100TG2015PTC099814. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Vamsi Pharma was incorporated on 16 July 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Vamsi Pharma has 4 deals on record (3 rights issues, 1 secondary share transfer); the latest was in January 2022.
The peers of Vamsi Pharma by revenue are Wayonext Pharmaceuticals Private Limited, JMM Formulation Private Limited, Anchor Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ravindra Nandlal Purohit ceased to be Director on 31 Mar 2024. Prashant Nalinaksh Garg ceased to be Additional Director on 15 Mar 2023. Prashant Nalinaksh Garg was appointed as Director on 02 Sep 2022. Vamsi Pharma has 7 board changes on record in total.
Yes, Vamsi Pharma is registered as an MSME under Udyam registration (number: UDYAM-TS-09-0046886).
Vamsi Pharma has 2 MSME Form 1 returns on record between 2022 and 2023, listing 22 overdue payments to 17 micro and small suppliers. The latest return was filed on 03 Feb 2024.
Vamsi Pharma can be reached through the website vamsipharma.com. Its registered office is in Hyderabad, Telangana, India.